Clinical Trials Logo

HIV Enteropathy clinical trials

View clinical trials related to HIV Enteropathy.

Filter by:
  • None
  • Page 1

NCT ID: NCT01828593 Completed - Clinical trials for HIV-associated Enteropathy

Impact of Serum-derived Bovine Immunoglobulin Protein Isolate, a Medical Food, on Nutritional Status in Patients With HIV-associated Enteropathy

Start date: April 2013
Phase: N/A
Study type: Interventional

The purpose of the study is to evaluate the effectiveness of the oral nutritional therapy serum-derived bovine immunoglobulin protein isolate (SBI) 2.5 g twice a day (BID) and SBI 5.0 g versus placebo on supporting nutrient absorption in HIV+ subjects with HIV-associated enteropathy.

NCT ID: NCT01374490 Completed - HIV Enteropathy Clinical Trials

Safety and Tolerability of Crofelemer for HIV-Associated Diarrhea

Start date: June 7, 2011
Phase: Phase 3
Study type: Interventional

This study is being conducted to evaluate the safety and tolerability of crofelemer 125 mg twice a day, taken orally, over 48 weeks of therapy in human immunodeficiency virus-positive (HIV+) subjects with diarrhea.

NCT ID: NCT01313910 Completed - HIV Clinical Trials

CCRC: A Project of the Treatment of HIV Enteropathy With ImmunoLin® Supplements

Start date: March 2011
Phase: Early Phase 1
Study type: Interventional

The purpose of the study is to see if ImmunoLin® will reduce the frequency of bowel movements and gastrointestinal (GI) symptoms in HIV volunteers with persistent GI symptoms. The study will also examine the effect of ImmunoLin® on the bacteria in the gut and the immune system in gut tissue as well as in the blood.

NCT ID: NCT00816842 Completed - Clinical trials for Malabsorption Syndromes

Plasma Citrulline Concentration in Tropical Enteropathy

Start date: October 1998
Phase: N/A
Study type: Observational

Citrulline is an amino acid produced in the intestine and in the liver, but the liver does not contribute significantly to circulating citrulline concentrations. The intestine is thus the only organ that normally releases significant amounts of citrulline into the blood stream. The investigators have designed a study looking at the value of measuring plasma citrulline concentration in patients with tropical enteropathy of mixed HIV status. The focus will be on the ability of the intestine to sustain the individual concerned from a nutritional standpoint. The investigators hypothesise that plasma citrulline concentration is a marker of small bowel absorptive integrity and an appropriate surrogate for HIV related enteropathy.